Introduction
Interference with microtubule function leads to defective mitotic spindle formation, cell cycle arrest in M-phase, and eventually to apoptosis or post-mitotic cell death. The use of microtubule interfering agents is therefore a promising strategy for anti-cancer therapy alone and as part of combined treatment modalities with cytotoxic agents [1] . The effects of microtubule interfering agents at the biochemical level are well investigated, but additional cytotoxic effects due to signaling interference have been identified, which merit further investigation [2] [3] [4] [5] .
We previously investigated the combined treatment modality of ionizing radiation (IR) with the novel, clinically relevant microtubule stabilizing agent patupilone (Epothilone B), and interestingly, the combination of patupilone with IR resulted in vitro only in an additive cytotoxic effect (against various cancer cell types) but in a supra-additive tumor growth delay against tumor xenografts derived from the same tumor cells [2, 4] . The accumulation of tumor cells in the most radiosensitive G2-M phase of the cell cycle represents the major rationale for the sensitization to IR [6] [7] [8] [9] , though other Sphase progression-related mechanisms have been observed as well [4] . Additional anti-vascular and anti-angiogenic effects might contribute to the supra-additive tumor growth delay observed in vivo, and indeed, direct targeting of endothelial cells [10] [11] [12] and indirect, anti-angiogenic interference with the secretion of pro-angiogenic factors from tumor cells have been proposed [2, 13] . Microtubule stabilizing and destabilizing agents block the nuclear translocation and correct assembly of the hypoxia inducible factor (HIF) by disrupting the structural organization of the microtubule cytoskeleton. In consequence, the downstream signaling of HIF-1 target genes in response to hypoxia is compromised [2] [3] 5] . A reduction of pro-angiogenic (and cytoprotective) cytokine secretion by patupilone via inhibition of HIF could contribute to this mechanism [14] [15] . However, such a link between microtubule-interfering agents and HIF-signaling has only been investigated at high-dose concentrations of these agents.
The group of microtubule stabilizing agents (MSA) are amongst the most promising chemotherapeutic agents for the treatment of non-small cell lung cancer. The MSA docetaxel is the only chemotherapeutic agent currently approved for first-and second-line treatment of advanced non-small cell lung cancer. Although single agent docetaxel as well as combined treatments with platinum-based agents have led to significant progress in the treatment of lung cancer, its use often results in strong side-effects [16] [17] [18] . In order to overcome such limitations, new MSA with fewer side-effects, superior pharmacological and anticancer activity are under investigation in order to maximize the induced benefits for lung cancer patients. At the same time and based on the immense technological improvements of current radiotherapy with regard to treatment conformality and accuracy radiotherapy is becoming standard of care for the management of lung cancer. As such, combined radiochemotherapy treatment modalities are also of high interest for this tumor entity.
Here we investigated the treatment response of low-dose, sub-nanomolar concentrations of patupilone alone and in combination with IR specifically on hypoxia-driven VEGF expression and secretion in the patupilone-sensitive lung adenocarcinoma cell line A549 and the mutant derivative A549.EpoB40, which is strongly resistant to patupilone due to a genetically defined β-tubulin-mutation [3, [19] [20] [21] .
Thereby we aim to further explore the interference of patupilone with the tumor-cell derived growth factor most relevant for tumor angiogenesis.
Materials and methods

Drugs and cell lines
Patupilone (epothilone B, EPO906) was provided by Novartis Pharma AG (Basel, Switzerland). The human cell line pair A549 and A549.EpoB40 was obtained from the laboratory of Dr. SB Horwitz.
Cell cultures, drug preparation and irradiation
The human non-small cell lung cancer lines A549 and A549.EpoB40 were grown in RPMI 1640 containing 10% (v/v) fetal bovine serum, 1% (v/v) penicillin-streptomycin and 1% (v/v) L-glutamine at 37ºC in 5% CO2. A549.EpoB40 is derived from A549 by stepwise selection with patupilone and contains a point mutation in class 1 β-tubulin (β292 from Gln to Glu) which is associated with a ~95-fold resistance to patupilone [20] . The A549.EpoB40 cell line was grown and maintained in medium containing 10 nM patupilone. For in vitro experiments, patupilone was dissolved in DMSO (1 mM stock solution) and further diluted with media containing 10% FCS.
Irradiation of cell cultures was carried out using a Gulmay 200 kV X-ray unit at 100 cGy/min at room temperature. For combined treatment and hypoxia experiments, cells were pretreated with patupilone 24 hours before applying hypoxia or hypoxia mimicking conditions. Cells were irradiated 4 hours thereafter.
Cultivation of cells under hypoxia
Hypoxia experiments with A549 and A549.EpoB40 were performed for various time spans at 0.2% or 1% oxygen using a Invivo2 400 hypoxia workstation (Biotrace International). Cells were preincubated with patupilone for 24 hours under normoxic conditions, followed by incubation in the hypoxia chamber or under hypoxia-mimicking conditions, using Dimethyloxaloylglycine (DMOG) (Biomol GmbH, Hamburg, Germany), a prolyl-4-hydroxylase inhibitor (0.25 and 1 mM, respectively) [2] .
Western blot analysis
A549 and A549.EpoB40 were cultivated in 6-well dishes, washed twice with ice cold PBS, and whole cell extracts were obtained by scraping cells with 150 μl of pre-cooled hypotonic lysis buffer (Laemmli-buffer (4% SDS, 15% glycerol, 0.125 M Tris HCl) and 2xSDS-buffer (20% glycerol, 0.100 M Tris, 0.1% bromphenol blue; 10% β-mercaptoethanol) 1:1) and immediately heated for 5 minutes at 95˚C on a heating block. Hypoxic probes were retrieved under hypoxic conditions. Proteins were resolved by 10% SDS-PAGE, followed by western blotting onto polyvinylidene difluoride membranes. Membranes were probed with the HIF-1α antibody (HIF-1α (H-206), Santa Cruz Biotecnology, Inc.). Antibody detection was achieved by enhanced chemoluminescence (Amersham, Piscataway, NJ) according to the protocol of the manufacturer. All experiments were carried out independently at least thrice.
Isolation and analysis of RNA
Total RNA was isolated using the Quiagen RNeasy Plus Mini Kit (Qiagen, Hombrechtikon, Switzerland). First-strand cDNA synthesis was performed with 1-5 mg total RNA using reverse transcriptase enzyme, and mRNA levels were measured by real-time quantitative PCR using a SybrGreen qPCR reagent kit (Applied Biosystems) in combination with a 7900 HT TaqMan rtPCR system (Applied Biosystems) and SDS manager 2.3, patch 3-software. Real-time PCR was carried out as recommended by the manufacturer. To verify equal input levels, β-actin was used as a housekeeping gene and the data were expressed as ratios relative to β-actin levels. The primers 
ELISA
Supernatants of cultured cells were centrifuged at 10'000 g to remove debris and stored at -80˚C. Cell numbers were manually counted after trypsination to allow correction to cell number. Total protein content of supernatant was measured with a Nanodrop spectrophotometer (Witec AG, Switzerland) at an absorbance of 280 nm. The concentration of VEGF-levels in the supernatant was determined using the commercially available Quantikine® Human VEGF Immunoassay kit (R&D Systems GmbH, Wiesbaden-Nordenstadt, Germany), following the manufacturer's description.
Statistical analysis
Experiments presented in the figures are representative of three or more different repetitions if not otherwise indicated. Statistical analysis was performed using GraphPad Prism5 software (GraphPad Software Inc.). Student's t-test was used to evaluate the differences between normoxic and hypoxic and between drug and IR treated samples. The level of significance was set at 0.05.
Results
Stabilization of microtubules leads to inhibition of the HIF pathway
The hypoxia-stabilized HIF-1α-subunit of the transcription factor HIF represents a major determinant for hypoxia-regulated expression of pro-angiogenic growth factors. To determine hypoxia-dependent HIF-1α stabilization on patupilone treatment, patupilone-sensitive lung adenocarcinoma A549 wildtype and patupilone-resistant A549.EpoB40 cells were pretreated for 24 hours with increasing concentrations of patupilone (0-1 nM) followed by incubation in 0.2% pO 2 or addition of the hypoxiamimicking agent DMOG (0.25 and 1 mM, respectively). Maximum stabilization of the HIF-1α subunit under hypoxic conditions was observed at 4 hours of hypoxic exposure and in hypoxia-mimicking conditions ( Fig. 1) and was reduced again to background levels at the 24 hour time point in both cell lines (data not shown). In the A549 wildtype cells HIF-1α stabilization was abrogated by patupilone in a dose-dependent way, while HIF-1α protein levels were not reduced in the A549.EpoB40 cells on patupilone treatment (Fig. 1) . HIF-1α stabilization in the A549.EpoB40 cells was only affected at approximately 100-fold higher concentrations of patupilone, which correlates to the 100-fold-reduced affinity of mutant β-tubulin to patupilone in these cells (data not shown).
We previously observed an at least additive reduction of microvessel density in tumor xenografts derived from A549-adenocarcinoma tumor cells on combined treatment with patupilone and IR [2] .
This might be due to a combined effect on the HIF-1α -dependent expression or secretion of proangiogenic factors such as the vascular endothelial growth factor (VEGF). Irradiation of cells alone did not affect HIF-1α-level but synergized with patupilone. When A549 wildtype cells were pretreated with low dose patupilone (0.2 nM and 0.5 nM; with only a minor effect on HIF-1α stability alone), followed by incubation with DMOG and irradiation 2 hours thereafter, HIF-1α-protein levels were even further reduced than after treatment with patupilone alone. No downregulation of HIF-1α was observed in the β-tubulin-mutated counterpart cells after treatment with either condition (Fig. 2) .
Downstream signaling of HIF at the level of VEGF mRNA is affected by treatment with patupilone
To determine the consequence of deregulated HIF-1α stability on the expression of the major proangiogenic factor VEGF, VEGF mRNA levels were quantified by real-time PCR. Incubation of cells for 24 h under hypoxic (0.2% pO 2 ) or hypoxia mimicking conditions (DMOG) resulted in a 6-and 4-fold upregulation of VEGF mRNA levels, in A549 wildtype and A549EpoB40 mutated lung adenocarcinoma cells, respectively (Fig. 3) . Similar to the effect on HIF-1α -stability, pretreatment with patupilone (0.5 nM) resulted in diminished VEGF mRNA upregulation in the A549 cells by 43% (p=0.002), but not in the patupilone-resistant A549.EpoB40 cells, when treated under hypoxic or hypoxia mimicking conditions. Under hypoxia-mimicking conditions irradiation alone (4 hours after start of DMOG-treatment) resulted in enhanced VEGF expression in the A549 wildtype cells but not in the A549EpoB40 cells, which are more radiation resistant [2] . The discrepancy between IR-downregulated HIF-1α-levels (see above) and IR-enhanced VEGF-mRNA levels might be due to the different time points of data collection. However and more important, the relative downregulation of VEGF mRNA levels in patupilone-pretreated cells was observed to a similar extent in irradiated as in unirradiated A549 wildtype cells (reduction by 45% of initial values (p=0.006), while patupilone treatment did not downregulate VEGF expression in irradiated A549.EpoB40 cells.
VEGF protein secretion with drug pretreatment is inhibited in A549
To determine the amount of secreted VEGF in response to treatment with IR and patupilone, cells were preincubated with patupilone for 24 hours, incubated under hypoxia mimicking conditions (for collected during a 12 hour interval of incubation under hypoxia-mimicking conditions (18 h-30 h time period) and were analyzed for VEGF protein levels by ELISA.
As expected from the real time PCR results, secreted VEGF levels in supernatants derived from DMOG-treated cells were 3-4-fold enhanced in both A549 wildtype and A549.EpoB40 mutated cells in comparison to supernatants derived from cells kept in normoxia. Of note, while irradiation enhanced VEGF mRNA levels in A549 cells kept under hypoxia-mimicking conditions (see above), no further increased VEGF protein level could be detected in supernatants derived from these cells.
Interestingly, in response to patupilone treatment (0.5 nM) a significant reduction in VEGF-secretion under normoxic (31%, p=0.008) as well as DMOG conditions (34%, p<0.001) was determined in the patupilone-sensitive cell line A549 (Fig. 4) 
Discussion
Here, we investigated the regulation of the hypoxia-inducible factor HIF-1α and its downstream target VEGF by the novel, clinically relevant microtubule stabilizing agent patupilone alone and in combination with ionizing radiation. The effect of patupilone was specifically tested in the lung adenocarcinoma cell line A549 at subnanomolar concentrations, which do not induce the classic MSAdependent M-phase arrest and have only minimal cytotoxic activity. Under hypoxia HIF-1α-protein levels were reduced by low-dose treatment with patupilone. Subsequently VEGF mRNA transcription was diminished, and reduced levels of secreted VEGF-protein were detected in cell supernatants.
Furthermore patupilone repressed IR-induced VEGF mRNA expression. The specificity of patupilone and the involvement of the microtubular system were evidenced by the lack of a treatment response in the mutated A549 cell line derivative harboring a specific β-tubulin mutation, which abrogates patupilone-binding.
A variety of microtubule targeting drugs has previously been described to exhibit anti-HIF properties in tumor cells exposed to hypoxia [3, 5] . 2-Methoxyestradiol and classic microtubule stabilizing (taxanes) and microtubule destabilizing (vincristine, discodermolide) agents downregulated HIF-1α at the posttranscriptional level resulting in reduced HIF-1α protein synthesis and subsequent reduced nuclear accumulation and transcriptional activity. Microtubule stabilizing agents may interfere with a regulated HIF-1α mRNA-microtubule association and guided nuclear import of the HIF-1α subunit into the nucleus [3, 5] . However these experiments were performed at concentrations of the respective compounds that strongly induced microtubule stabilization and destabilization, respectively and treatment-dependent cell cycle redistribution into G2-M phase. Here we demonstrate that low-dose concentrations of patupilone (epothilone B) strongly reduce HIF-1α protein levels and subsequent downregulation of the major downstream target VEGF at up to 100-fold lower concentrations, which do not result in microtubule interference-related G2-M cell cycle redistribution, and that patupilone counteracts a potential pro-angiogenic stress response [23] . Furthermore these low concentrations of patupilone are still β-tubulin-specific, without any effect in the A549-mutated cell line and are sufficient to sensitize for ionizing radiation ( [2, 4] , and data not shown).
Despite direct in vitro cytotoxicity against endothelial cells [11] Regulation of HIF-1α in response to irradiation is complex and dependent on multiple factors including hypoxia and reoxygenation-enhanced generation of reactive oxygen species [14] [15] .
Furthermore the treatment response in vitro might not reflect the in vivo situation with its dynamic adaptation to microenvironmental changes in response to radiotherapy. Here we determined multiple endpoints in response to IR alone and in combination with patupilone in the two related adenocarcinoma cell lines, (HIF-1α protein levels, VEGF expression and secretion). In part they are difficult to be reconciled. For example IR enhanced VEGF expression under hypoxic condition, but no enhanced HIF-1α protein levels could be detected in irradiated cells. This might be due to undetected posttranslational modifications, which increases the transcriptional activity of HIF-1α, but might also be due to incomplete analysis of HIF-1α due to technical limitations. In this study, patupilone-reduced VEGF-mRNA expression was normalized to β-actin-housekeeping gene expression and is therefore not affected by a small reduction of cell viability at patupilone-concentrations used (20% at 0.5 nM, data not shown). However we can not exclude that patupilone-reduced VEGF-secretion might in part derive from patupilone-affected cell viability at a later time point. On the other hand MSA may also interfere with the secretion of vesicles and proteases required for VEGF-release along a dynamic microtubular system [26] , which is currently investigated as part of ongoing studies. 
